Your browser doesn't support javascript.
loading
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer.
Keller, Rachel B; Mazor, Tali; Sholl, Lynette; Aguirre, Andrew J; Singh, Harshabad; Sethi, Nilay; Bass, Adam; Nagaraja, Ankur K; Brais, Lauren K; Hill, Emma; Hennessey, Connor; Cusick, Margaret; Del Vecchio Fitz, Catherine; Zwiesler, Zachary; Siegel, Ethan; Ovalle, Andrea; Trukhanov, Pavel; Hansel, Jason; Shapiro, Geoffrey I; Abrams, Thomas A; Biller, Leah H; Chan, Jennifer A; Cleary, James M; Corsello, Steven M; Enzinger, Andrea C; Enzinger, Peter C; Mayer, Robert J; McCleary, Nadine J; Meyerhardt, Jeffrey A; Ng, Kimmie; Patel, Anuj K; Perez, Kimberley J; Rahma, Osama E; Rubinson, Douglas A; Wisch, Jeffrey S; Yurgelun, Matthew B; Hassett, Michael J; MacConaill, Laura; Schrag, Deborah; Cerami, Ethan; Wolpin, Brian M; Nowak, Jonathan A; Giannakis, Marios.
Afiliação
  • Keller RB; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Mazor T; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.
  • Sholl L; Center for Advanced Molecular Diagnostics, Brigham & Women's Hospital & Harvard Medical School, Boston, MA.
  • Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Singh H; Broad Institute of Harvard and MIT, Cambridge, MA.
  • Sethi N; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Bass A; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Nagaraja AK; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Brais LK; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Hill E; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Hennessey C; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Cusick M; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Del Vecchio Fitz C; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Zwiesler Z; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.
  • Siegel E; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.
  • Ovalle A; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.
  • Trukhanov P; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.
  • Hansel J; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.
  • Shapiro GI; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.
  • Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Biller LH; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Chan JA; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Corsello SM; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Enzinger AC; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Enzinger PC; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Mayer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • McCleary NJ; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Patel AK; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Perez KJ; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Rahma OE; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Wisch JS; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Yurgelun MB; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Hassett MJ; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • MacConaill L; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Schrag D; Center for Advanced Molecular Diagnostics, Brigham & Women's Hospital & Harvard Medical School, Boston, MA.
  • Cerami E; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Wolpin BM; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.
  • Nowak JA; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.
  • Giannakis M; Center for Advanced Molecular Diagnostics, Brigham & Women's Hospital & Harvard Medical School, Boston, MA.
JCO Precis Oncol ; 7: e2200342, 2023 01.
Article em En | MEDLINE | ID: mdl-36634297
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicina de Precisão / Neoplasias Gastrointestinais Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Marrocos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicina de Precisão / Neoplasias Gastrointestinais Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Marrocos